Kanabo Research’s leadership team is made up of experienced medical industry professionals in a variety of fields shaping the medical Cannabis industry, including biopharmaceuticals, pharmaceutical R&D, Drug Delivery Systems (DDS), clinical research, medical patents, vaporizer technology, botanical extracts, and more. Featured members of Kanabo’s leadership team are included below.

Avihu Tamir – Founder & CEO

Avihu Tamir Kanabo ResearchCannabis Entrepreneur with five years hands-on experience in multiple Cannabis ventures, currently active as a partner in a licensed Israeli medical Cannabis cultivation company. He is a former senior strategy consultant at Accenture; and founder of Teva Nature, the leading vaporizer company in Israel.

David Tsur – Board Chair

David Tsur Kanabo Research
Co-founder and former Chief Executive Officer of Kamada, a leading Israeli pharmaceutical company. He currently serves as Kamada’s Active Deputy Board Chair. Prior to founding Kamada, Mr. Tsur was CEO of Arad Systems and RAD Chemicals. He has also held various positions in the Israeli Ministry of Economy, including Chief Economist and Commercial Attaché in Argentina and Iran.

Doron Friedman, Ph.D. – Scientific Director

Doron Friedman Kanabo Research
Specialist in pharmaceutical R&D with over 25 years experience as biomedical entrepreneur and executive. Dr. Friedman is the inventor of Bausch and Lomb’s Lotemax eye drops, and holds over 80 granted patents,making him the most prolific inventor in Israel. He served as Director of Pharmaceutical Development at Pharmos Corp, Chief Technology Officer of Foamix Ltd, and continues to consult numerous companies on pharmaceutical development.

Nachshon Knoller, M.D. – Medical Director

Nachshon Knoller Kanabo Research
World-renowned neurosurgeon, currently Director of Spinal Surgery Division at Sheba Medical Center in Tel-Hashomer, Israel. Dr. Knoller serves as Scientific Advisory Board Member of Proneuron Biotechnologies, Inc. and has served as an Advisory Board Member of Mazor Surgical Robotics Ltd. Research activities include emerging medication treatments and cell therapy (macrophages) for traumatic brain and spinal injuries.